- Package
- 1 mg
- Purity
- 98+%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 131436-22-1
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
131436-22-1
PubChem CID
131379
Molecular Formula
C16H13NO7
Molecular Weight
331.28 g/mol
Exact Mass
331.069202
InChIKey
GEWLYFZWVLXQME-MRXNPFEDSA-N
IUPAC Name
(9aS)-8-acetyl-1,3,7-trihydroxy-9a-methyl-9-oxodibenzofuran-4-carboxamide
SMILES String
CC(=O)C1=C(C=C2[C@@](C1=O)(C3=C(C=C(C(=C3O2)C(=O)N)O)O)C)O
No physical property values available.
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Cercosporamide (CAS 131436-22-1) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C16H13NO7 and molecular weight 331. 28 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens) — 3 assays; MAP kinase-interacting serine/threonine-protein kinase 1 (Homo sapiens) — 3 assays; Protein kinase C beta type (Homo sapiens) — 2 assays; Protein kinase C alpha type (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
MAP kinase-interacting serine/threonine-protein kinase 2
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 3 documents · best pChEMBL 7.42
Experimental evidence source: ChEMBL
MAP kinase-interacting serine/threonine-protein kinase 1
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 3 documents · best pChEMBL 7.37
Experimental evidence source: ChEMBL
Protein kinase C beta type
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 6.52
Experimental evidence source: ChEMBL
Protein kinase C alpha type
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 2 documents · best pChEMBL 6
Experimental evidence source: ChEMBL
Safety and handling reference content is available through documentation requests.
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Cercosporamide is identified by CAS 131436-22-1, with molecular formula C16H13NO7, molecular weight 331.28, InChIKey GEWLYFZWVLXQME-MRXNPFEDSA-N.
ChEMBL contains qualifying experimental assay evidence associated with MAP kinase-interacting serine/threonine-protein kinase 2, MAP kinase-interacting serine/threonine-protein kinase 1, Protein kinase C beta type, Protein kinase C alpha type. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.